ZA941956B - Purification of factor VII - Google Patents

Purification of factor VII

Info

Publication number
ZA941956B
ZA941956B ZA941956A ZA941956A ZA941956B ZA 941956 B ZA941956 B ZA 941956B ZA 941956 A ZA941956 A ZA 941956A ZA 941956 A ZA941956 A ZA 941956A ZA 941956 B ZA941956 B ZA 941956B
Authority
ZA
South Africa
Prior art keywords
purification
factor vii
vii
factor
Prior art date
Application number
ZA941956A
Other languages
English (en)
Inventor
Tony Jorgensen
Anders H Pedersen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA941956B publication Critical patent/ZA941956B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Catalysts (AREA)
ZA941956A 1993-03-31 1994-03-21 Purification of factor VII ZA941956B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93382A DK38293D0 (da) 1993-03-31 1993-03-31 Fremstilling af proteiner

Publications (1)

Publication Number Publication Date
ZA941956B true ZA941956B (en) 1994-09-30

Family

ID=8092871

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA941956A ZA941956B (en) 1993-03-31 1994-03-21 Purification of factor VII

Country Status (16)

Country Link
US (1) US5700914A (xx)
EP (1) EP0691984A1 (xx)
JP (1) JPH08508264A (xx)
CN (1) CN1039231C (xx)
AU (1) AU677309B2 (xx)
CA (1) CA2159313A1 (xx)
CZ (1) CZ253395A3 (xx)
DK (1) DK38293D0 (xx)
FI (1) FI954649A0 (xx)
HU (1) HUT72712A (xx)
IL (1) IL109164A0 (xx)
NO (1) NO953883L (xx)
PL (1) PL310887A1 (xx)
TW (1) TW278079B (xx)
WO (1) WO1994022905A1 (xx)
ZA (1) ZA941956B (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19538716A1 (de) * 1995-10-18 1997-04-24 Behringwerke Ag Verfahren zur Quantifizierung von aktiviertem Gerinnungsfaktor VII (FVIIa)
DE19538715A1 (de) * 1995-10-18 1997-04-30 Behringwerke Ag Verfahren zur Reinigung von Faktor VII und aktiviertem Faktor VII
DK1308456T3 (da) 1998-05-06 2007-12-27 Genentech Inc Antistofoprensning ved ionbytterkromatografi
AT408613B (de) * 1998-06-17 2002-01-25 Immuno Ag Pharmazeutisches faktor vii-präparat
WO2001058935A2 (en) 2000-02-11 2001-08-16 Maxygen Aps FACTOR VII OR VIIa-LIKE MOLECULES
IL162239A0 (en) 2001-12-21 2005-11-20 Novo Nordisk Healthcare Ag Liquid composition of factor vii polypeptides
US20040009918A1 (en) * 2002-05-03 2004-01-15 Hanne Nedergaard Stabilised solid compositions of modified factor VII
EP2283856B1 (en) 2002-06-21 2017-09-20 Novo Nordisk Health Care AG Stabilised solid compositions of factor VIIa polypeptides
AU2004221758B2 (en) * 2003-03-18 2010-07-22 Novo Nordisk Health Care Ag Method for the production of GLA-residue containing serine proteases
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
CA2525224A1 (en) 2003-05-23 2004-12-02 Michael Bech Jensen Protein stabilization in solution
ATE547114T1 (de) * 2003-06-25 2012-03-15 Novo Nordisk Healthcare Ag Flüssige zusammensetzungen von factor vii polypeptiden
ES2335994T3 (es) * 2003-07-01 2010-04-07 Novo Nordisk Health Care Ag Composicion farmaceutica liquida, acuosa de polipeptidos factor vii.
ES2574581T3 (es) 2003-08-14 2016-06-20 Novo Nordisk Health Care Ag Composición farmacéutica líquida acuosa de polipéptidos de tipo Factor VII
CN1890257A (zh) 2003-12-01 2007-01-03 诺和诺德医疗保健公司 液体因子ⅶ组合物的病毒过滤
EP2298287B1 (en) * 2003-12-19 2018-04-11 Novo Nordisk Health Care AG Stabilised compositions of factor VII polypeptides
EP1831242B1 (en) * 2004-12-23 2012-09-26 Novo Nordisk Health Care AG Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest
PT1841863E (pt) * 2005-01-14 2010-10-25 Bayer Healthcare Llc Método para a purificação de factor vii
PL1907540T3 (pl) * 2005-07-22 2013-05-31 Bayer Healthcare Llc Aktywacja czynnika VII w roztworze
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
EP1971355B1 (en) * 2005-12-20 2020-03-11 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
WO2009158704A2 (en) 2008-06-27 2009-12-30 Duke University Therapeutic agents comprising elastin-like peptides
CN103539852B (zh) * 2012-07-12 2015-08-12 上海泰龙生物医药科技有限公司 一种从细胞培养液中分离纯化重组人凝血八因子的方法
EP2687595B1 (en) 2012-07-19 2018-05-30 Laboratoire Français du Fractionnement et des Biotechnologies Method for purifying transgenic factor VII
AU2013331240B8 (en) 2012-10-17 2016-11-24 The Procter & Gamble Company Strip for the delivery of an oral care active and methods for applying oral care actives
EP3560946B1 (en) 2016-12-22 2022-02-02 KM Biologics Co., Ltd. Chromatographic method for collecting blood coagulation factor vii with high yield

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981952A (en) * 1988-10-04 1991-01-01 Eli Lilly And Company Method for the purification of vitamin K-dependent proteins

Also Published As

Publication number Publication date
CA2159313A1 (en) 1994-10-13
WO1994022905A1 (en) 1994-10-13
JPH08508264A (ja) 1996-09-03
CN1121723A (zh) 1996-05-01
FI954649A (fi) 1995-09-29
IL109164A0 (en) 1994-06-24
US5700914A (en) 1997-12-23
DK38293D0 (da) 1993-03-31
AU677309B2 (en) 1997-04-17
NO953883L (no) 1995-11-28
PL310887A1 (en) 1996-01-08
NO953883D0 (no) 1995-09-29
FI954649A0 (fi) 1995-09-29
HU9502846D0 (en) 1995-12-28
HUT72712A (en) 1996-05-28
AU6423994A (en) 1994-10-24
EP0691984A1 (en) 1996-01-17
CZ253395A3 (en) 1996-01-17
CN1039231C (zh) 1998-07-22
TW278079B (xx) 1996-06-11

Similar Documents

Publication Publication Date Title
IL109164A0 (en) Purification of factor VII
GB2274412B (en) Gas purification
ZA947090B (en) Purification of fluids by adsorption
GB2280858B (en) Water purifier with different degrees of purification
HU9302059D0 (en) Differentiating factor of megacaryocyte
HK1001330A1 (en) Purification of fluoropolymers
GB9421247D0 (en) Purification of indigo
GB9210081D0 (en) Purification process
GB9206667D0 (en) Purification process
GB9417118D0 (en) Purification of pentafluoroethane
ZA932553B (en) New use of B-carbolines
EP0424316A3 (en) Purification of 2-aryl-2h-benzotriazoles
ZA944577B (en) Preparation of aminopropionitriles
GB2275266A8 (en) Preparation of 2-methyl-3-aminobenzotrifluoride
GB9300501D0 (en) Purification of immunoglobulin
HU9204061D0 (en) Purification method
GB9417815D0 (en) Purification of pentafluoroethane
GB9309400D0 (en) Purification of fluoronucleosides
GB9324912D0 (en) Purification of gases
GB9309453D0 (en) Polyester purification
GB9215562D0 (en) Purification of pentafluoroethane
GB9215563D0 (en) Purification of pentafluoroethane
PL299577A1 (en) Method of purifying manganese
GB9313575D0 (en) Preparation of solutions
PL55382Y1 (en) Set of symmetrisers